about
Molecular Insight into Gut Microbiota and Rheumatoid ArthritisThe human microbiome and juvenile idiopathic arthritisAlteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease StatusEffect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis.Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents.Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.Evaluation and Treatment of Childhood Enthesitis-Related Arthritis.The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.An overview of investigational new drugs for treating ankylosing spondylitis.Autoinflammation and HLA-B27: Beyond Antigen Presentation.Propionibacterium acnes, Coagulase-Negative Staphylococcus, and the "Biofilm-like" Intervertebral Disc.Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation.Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice.Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis.A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis.Sialoglycoprotein isolated from the eggs of Carassius auratus prevents bone loss: an effect associated with the regulation of gut microbiota in ovariectomized rats.Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and FutureERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis
P2860
Q26752055-E092E45B-4CDA-444F-8314-A4886F4D777EQ28072377-40101977-7AAC-4111-9BBB-75AAA52CA056Q28821054-009985B8-1E49-423F-8A64-5931FC215924Q33468052-62040FE5-4C95-4754-BC23-FFC3635D536EQ33880811-6B14A5C3-AD98-4330-9240-5AFC1CE2FE96Q36197744-86AD1B93-A561-454A-99A2-82462653A39EQ36498631-DDD4DA53-FD73-4399-B95E-7303B8844CEDQ38380973-0A58603E-0A0C-4DD6-8DCB-C241D338B5FAQ38631462-760E4593-A356-4274-84FE-013CDE153670Q38845301-51C62ADC-26C1-4523-8C39-3AC41AF4A619Q39351067-67E9AF77-9358-49C8-BD95-C15B8527BFB2Q40231414-A3E92BF0-2F31-4690-925A-4DD6B902977FQ41677436-3E816345-EB9F-4F9F-8FC5-EA1D436585ABQ46521495-1823CCAD-D1AA-4892-97C8-D5DB9D002685Q48358990-2E236347-29BF-4AFE-8A4D-46E5728A0EEFQ51110463-43C7E962-E2C9-491A-85A5-CB34681F5252Q53828369-9660BDB6-0208-4088-A935-A5EBFBE9F387Q58567074-BF4E3539-8649-4E84-BE41-1E004E57F62EQ58737249-67DB3556-6768-40E2-A2D5-C54DB48BED70
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The intestinal microbiome in spondyloarthritis
@ast
The intestinal microbiome in spondyloarthritis
@en
The intestinal microbiome in spondyloarthritis
@nl
type
label
The intestinal microbiome in spondyloarthritis
@ast
The intestinal microbiome in spondyloarthritis
@en
The intestinal microbiome in spondyloarthritis
@nl
prefLabel
The intestinal microbiome in spondyloarthritis
@ast
The intestinal microbiome in spondyloarthritis
@en
The intestinal microbiome in spondyloarthritis
@nl
P2093
P2860
P3181
P1476
The intestinal microbiome in spondyloarthritis
@en
P2093
James T. Rosenbaum
Mark Asquith
Robert A. Colbert
Tejpal Gill
P2860
P304
P3181
P356
10.1097/BOR.0000000000000187
P407
P577
2015-07-01T00:00:00Z